Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma

被引：1
作者：
Tam, Constantine S.
Simpson, David
Opat, Stephen
Kim, Won Seog
Wang, Michael
Cull, Gavin
Johnston, Patrick B.
Munoz, Javier
Lee, Won-Sik
Marlton, Paula
Gottlieb, David
Wang, Lai
Huang, Jane
Hilger, James
Xue, Ling
Ro, Sunhee
Trotman, Judith
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
152
引用
收藏
页数：3
相关论文
共 50 条
[31]   Treatment of elderly patients with aggressive non-Hodgkin's lymphoma [J].
Fridrik, MA .
ONKOLOGIE, 1998, 21 (03) :251-254
[32]   Antioxidant status in patients with aggressive non Hodgkin's lymphoma. [J].
Dumontet, C ;
Lachenal, F ;
Thieblemont, C ;
Arnaud, P ;
Hequet, O ;
Salles, G ;
Coiffier, B ;
Drai, J .
BLOOD, 2001, 98 (11) :339A-339A
[33]   Response assessment of aggressive and indolent non-Hodgkin's lymphoma by revised integrated international workshop criteria [J].
Brepoels, Lieselot ;
Stroobants, Sigrid ;
Verhoef, Gregor ;
De Wolf-Peeters, Christiane ;
Spaepen, Karoline ;
Vandenberghe, Peter ;
Thomas, Jose ;
Bormans, Guy ;
Mortelmans, Luc .
ANNALS OF ONCOLOGY, 2006, 17 :197-197
[34]   Rituximab is a new option for patients with relapsed indolent non- Hodgkin's lymphoma [J].
不详 .
Drugs & Therapy Perspectives, 1999, 14 (5) :1-5
[35]   Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma [J].
Naumann, R ;
Beuthien-Baumann, B .
CLINICAL LYMPHOMA, 2003, 4 (01) :50-51
[36]   Utilization of healthcare services by. aggressive and indolent non-Hodgkin's lymphoma (NHL) patients compared to the general population. [J].
Kutikova, L ;
Bowman, L ;
Chang, S ;
Long, S .
BLOOD, 2002, 100 (11) :503B-503B
[37]   Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma [J].
O'Connor, OA ;
Wright, J ;
Moskowitz, C ;
Muzzy, J ;
MacGregor-Cortelli, B ;
Stubblefield, M ;
Straus, D ;
Portlock, C ;
Hamlin, P ;
Choi, E ;
Dumetrescu, O ;
Esseltine, D ;
Trehu, E ;
Adams, J ;
Schenkein, D ;
Zelenetz, AD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :676-684
[38]   Analysis of 371 cases of Non-Hodgkin's Lymphoma : Answer of Longstanding Controversial Cutoff Value of FDG Uptake Between Aggressive and Indolent Non-Hodgkin's Lymphoma [J].
Alobthani, Galal ;
Isohashi, Kayako ;
Watabe, Tadashi ;
Tatsumi, Mitsuaki ;
Kato, Hiroki ;
Shimosegawa, Eku ;
Hatazawa, Jun .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58
[39]   European experiences on aggressive non-Hodgkin's lymphoma in elderly patients [J].
Fratino, L ;
Bernardi, D .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 51 (03) :229-240
[40]   Treatment of elderly patients with aggressive non-Hodgkin's lymphoma. [J].
Paccalin, M ;
Lacotte-Thierry, L ;
Delwail, V .
REVUE DE MEDECINE INTERNE, 2002, 23 (07) :632-637
12345